已收盤 01-09 16:00:00 美东时间
-0.440
-1.76%
今日重点评级关注:HC Wainwright & Co.:维持奥麦罗制药"买入"评级,目标价从20美元升至40美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从26美元升至27美元
01-09 20:22
Susquehanna upgraded Caesars Entertainment (CZR) to a Positive rating after having the casino stock slotted at Neutral. As part of its valuation call, the firm maintains that the stock’s risk-reward p...
01-09 01:07
Susquehanna analyst Joseph Stauff upgrades Caesars Entertainment (NASDAQ:CZR) from Neutral to Positive and raises the price target from $25 to $31.
01-08 20:47
Nevada has eliminated a disseminator model for horse racing data and simulcasts that was over 80 years old and replaced it with a more flexible framework that could benefit the casino industry as ra...
01-03 23:22
The S&P 500 consumer discretionary sector has struggled to keep pace with the broader market in 2025, gaining +7.2% year-to-date, falling short of the S&P 500’s (SP500) overall performance. The secto...
2025-12-20 01:05
今日重点评级关注:HC Wainwright & Co.:维持BioCryst Pharma"买入"评级,目标价从30美元升至32美元;TD Cowen:上调Milestone Pharmaceuticals评级至"买入",目标价8美元
2025-12-16 09:36
Caesars Entertainment, Inc. (NASDAQ:CZR) ("Caesars") today announced a partnership with Rampart Casino at The Resort at Summerlin to open a Caesars Sportsbook inside the property, pending Nevada Gaming Commission
2025-12-16 00:16
The latest update is out from Caesars Entertainment ( ($CZR) ). On December 3, ...
2025-12-04 06:29
Shares of travel companies are trading higher ahead of the Thanksgiving holiday...
2025-11-26 00:39
今日重点评级关注:Canaccord Genuity:维持Fractyl Health"买入"评级,目标价从6美元升至8美元;HC Wainwright & Co.:维持MediWound"买入"评级,目标价从31美元升至36美元
2025-11-24 11:23